Evidence map›Paper›PMID 39941917›Full record

ArticleCancers2025

Predictors of the Development of Gastric Cancer in Post-

Kazuhiro Mizukami, Masaaki Kodama, Yuka Hirashita, Masahide Fukuda, Sotaro Ozaka, Koshiro Tsutsumi, Ryota Sagami, Kensuke Fukuda, Ryo Ogawa, Kazunari Murakami

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Gastric intestinal metaplasia: Management and surveillance strategies.World journal of gastrointestinal pathophysiology · 2026
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Kazuhiro MizukamiDepartment of Gastroenterology, Faculty of Medicine, Oita University, 1-1, Idaigaoka, Hasama, Yufu 879-5593, Japan.ORCID 0000-0002-3148-8884
Masaaki KodamaDepartment of Advanced Medical Sciences, Faculty of Medicine, Oita University, 1-1, Idaigaoka, Hasama, Yufu 879-5593, Japan.ORCID 0000-0003-0131-9470
Yuka HirashitaDepartment of Gastroenterology, Faculty of Medicine, Oita University, 1-1, Idaigaoka, Hasama, Yufu 879-5593, Japan.
Masahide FukudaDepartment of Gastroenterology, Faculty of Medicine, Oita University, 1-1, Idaigaoka, Hasama, Yufu 879-5593, Japan.
Sotaro OzakaDepartment of Gastroenterology, Faculty of Medicine, Oita University, 1-1, Idaigaoka, Hasama, Yufu 879-5593, Japan.ORCID 0000-0002-6283-7012
Koshiro TsutsumiDepartment of Gastroenterology, Faculty of Medicine, Oita University, 1-1, Idaigaoka, Hasama, Yufu 879-5593, Japan.
Ryota SagamiDepartment of Gastroenterology, Faculty of Medicine, Oita University, 1-1, Idaigaoka, Hasama, Yufu 879-5593, Japan.ORCID 0000-0003-4961-3521
Kensuke FukudaDepartment of Gastroenterology, Faculty of Medicine, Oita University, 1-1, Idaigaoka, Hasama, Yufu 879-5593, Japan.
Ryo OgawaDepartment of Gastroenterology, Faculty of Medicine, Oita University, 1-1, Idaigaoka, Hasama, Yufu 879-5593, Japan.
Kazunari MurakamiDepartment of Gastroenterology, Faculty of Medicine, Oita University, 1-1, Idaigaoka, Hasama, Yufu 879-5593, Japan.ORCID 0000-0003-2668-5039

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

objectivesAlthough

methodsPatients who underwent

resultsThe GC group was older than the non-GC group at the time of eradication, had lower serum pepsinogen I/II levels, had severe endoscopic atrophic changes, had higher activity at the antrum, and inflammation and intestinal metaplasia (IM) at the corpus on updated Sydney system scoring. On long-term follow-up after eradication, the GC group had a wider range of endoscopic mucosal atrophy and a lower serum pepsinogen I/II ratio at any time point.

conclusionsEndoscopic mucosal atrophy and the serum pepsinogen I/II ratio are useful predictors of GC in patients post

Indexed as

endoscopic atrophyeradicationgastric cancerHelicobacter pylorilong-term follow-upserum pepsinogen

Identifiers

PMID39941917
PMCPMC11816399

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.